ELEDON PHARMACEUTICALS INC (ELDN) Stock Income Statement
USA - NASDAQ:ELDN - US28617K1016 - Common Stock
2.74 USD
+0.03 (+1.11%)
2.74 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 87.90M | 70.58M | 43.00M | 39.78M | 36.87M | |||
| Research and Development | 68.25M | 51.96M | 30.31M | 27.08M | 23.74M | |||
| Selling, General, and Administrative Expenses | 19.65M | 18.61M | 12.69M | 12.70M | 13.13M | |||
| Operating Income | -87.90M | -70.58M | -43.00M | -39.78M | -36.87M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Other Income/Expense | 102.98M | 34.82M | -73.54M | 460.00K | 10.00K | |||
| Non Recurring Items | N/A | N/A | 0.00 | -48.65M | 0.00 | |||
| Income Before Taxes | 15.07M | -35.75M | -116.54M | -87.97M | -36.86M | |||
| Income Tax | N/A | 431.00K | 0.00 | 0.00 | -2.35M | |||
| Net Income | -10.31M | -36.18M | -116.54M | -87.97M | -34.51M | |||
| EBITDA | N/A | N/A | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.21 | -0.75 | -4.73 | -6.16 | -2.33 | |||
| Non GAAP EPS | 0.14 | -1.05 | -1.79 | -2.76 | -2.32 | |||
| Statistics | ||||||||
All data in USD